• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

    5/14/26 4:15:00 PM ET
    $BGMS
    Get the next $BGMS alert in real time by email

    KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ:BGMS, "BGMS" or the "Company")), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced first quarter financial results and provided a business update.

    Highlights of the first quarter ended March 31, 2026, or in some cases shortly thereafter, include:

     ●In March, trading of the Company's 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol "BGMSP") was suspended and a Form 25-NSE was filed with the Securities and Exchange Commission, which removed the Company's securities from listing and registration on The Nasdaq Stock Market. The delisting did not affect the Company's Common Stock (listed on The Nasdaq Capital Market under the symbol "BGMS").

     ●In April, the Board of Directors of the Company declared a quarterly cash dividend of $0.15 per share on the Company's 6% Convertible Exchangeable Preferred Stock, which cash dividend was paid on May 1, 2026, to holders of record as of the close of business on April 23, 2026.



    Datuk Dr. Doris Wong Sing Ee, Chief Executive Officer of the Company, commented, "We are pleased to report our first quarter 2026 results, which reflect meaningful progress in our strategic transformation. Since completing the acquisition of Fitters Sdn. Bhd. in September 2025, we have successfully transitioned our operations to focus on fire safety protection and distribution, and we are encouraged by the early momentum in this business, which generated $0.8 million in product revenue during the quarter." "Our team has also made significant strides in strengthening our cost structure. General and administrative expenses declined by approximately $3.8 million compared to the prior-year quarter, reflecting both the normalization of costs following the changes of control in 2025 and the disciplined approach of our current management team. We believe this leaner operating profile positions BGMS well as we scale our fire safety operations.

    "While we reported a modest net loss of $0.2 million for the quarter, we remain confident in our path forward. With $3.3 million in cash and cash equivalents on hand, we estimate that our current resources will fund planned expenditures into the fourth quarter of 2026. We remain focused on executing our growth strategy, expanding our fire safety product and service offerings, and driving long-term value creation for our shareholders."

    Financial Highlights

    As of March 31, 2026, cash and cash equivalents totaled $3.3 million, compared to $3.5 million as of December 31, 2025.

    Net cash used in operating activities was $0.3 million for the three months ended March 31, 2026. The Company estimates that its current cash resources will fund planned expenditure into the fourth quarter of 2026.

    Following the acquisition of Fitters Sdn. Bhd. on September 12, 2025, product revenue from sales and distribution of fire safety equipment was $0.8 million for the three months ended March 31, 2026.

    Cost of sales related to sales and distribution of fire safety equipment was $0.6 million for the three months ended March 31, 2026.

    General and administrative expenses decreased by approximately $3.8 million from $4.2 million for the three months ended March 31, 2025 to $0.4 million for the three months ended March 31, 2026, due to several one-time costs associated with the two changes of control of the Company during the prior period and lower operating costs of the company under current management.

    Total other income, net, for the three months ended March 31, 2026, increased by approximately $71,000 from $8,000 for the three months ended March 31, 2025 to $79,000 for the three months ended March 31, 2026, due largely to foreign exchange gains.

    Income tax provision for the three months ended March 31, 2026, was approximately $30,000 and related to our fire safety business, acquired in September 2025. There was no income tax provision for the three months ended March 31, 2025.

    Net income from discontinued operations was $4.1 million for the three months ended March 31, 2025 and relates to our former operations from biopharmaceutical activities. The net income consisted of operating losses of $0.8 million, offset by a gain on deconsolidation of our former subsidiary of $4.9 million.

    Net loss for the three months ended March 31, 2026, was $0.2 million, compared to $0.1 million for the same period in 2025.

    About Bio Green Med Solution, Inc.

    BGMS is a diversified company that was formerly engaged in the biopharmaceutical industry but as of September 2025 has shifted its operations to focus on provision of fire safety protection and distribution activities. Specifically, on September 12, 2025, the Company completed its acquisition of Fitters Sdn. Bhd., a Malaysia-based group specializing in fire protection products and services. Headquartered in Malaysia, the Company is now focused on advancing opportunities across these distinct sectors whilst maintaining its commitment to driving long-term value creation for shareholders. For additional information, please visit www.bgmsglobal.com.

    Forward-looking Statements

    Except for historical information, certain matters discussed in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance and involve various assumptions, known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by words such as "may," "will," "should," "expects," "intends," "plans," "anticipates," "believes," "estimates," "predicts," "potential" or other comparable words. Actual results, performance or outcomes may differ materially from those expressed or implied by these forward-looking statements and may not align with historical performance and events due to a number of factors, including those discussed in the sections of our annual report on Form 10-K entitled "Cautionary Statement Regarding Forward-Looking Statements" and "Risk Factors," and those discussed in our Form 10-Q quarterly reports filed after such annual report. BGMS's SEC filings are readily obtainable at no charge at www.sec.gov, as well as on its own investor relations website at https://investor.bgmsglobal.com/sec-filings. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and caution should be exercised against placing undue reliance upon such statements, which are based only on information currently available to us and speak only as of the date hereof. We are under no duty to update publicly any of the forward-looking statements after the date of this earnings press release, whether as a result of new information, future events or otherwise, except as required by law.

    SOURCE:

    Bio Green Med Solution, Inc.

    info@bgmsglobal.com

    BIO GREEN MED SOLUTION, INC.

    CONSOLIDATED STATEMENTS OF OPERATIONS (LOSS)

    (In $000s, except share and per share amounts)

      Three Months Ended 
      March 31, 
      2026  2025 
           
    Revenues:        
    Product revenue - fire safety $778  $- 
    Revenues $778  $- 
             
    Operating expenses:        
    Cost of sales  635   - 
    General and administrative  389   4,214 
    Total operating expenses  1,024   4,214 
    Operating loss  (246)  (4,214)
    Other income (expense):        
    Foreign exchange gains (losses)  39   (8)
    Interest income  9   6 
    Other income, net  31   10 
    Total other income, net  79   8 
    Loss from continuing operations before taxes  (167)  (4,206)
    Income tax provision  (30)  - 
    Net loss from continuing operations  (197)  (4,206)
    Discontinued operations:        
    Operating losses from discontinued operations  -   (822)
    Gain on deconsolidation of subsidiary  -   4,947 
    Net income from discontinued operations  -   4,125 
    Net loss  (197)  (81)
    Dividend on convertible exchangeable preferred shares  (20)  - 
    Net loss applicable to common shareholders $(217) $(81)
    Basic and diluted earnings per common share:        
    Net loss per share, continuing operations – basic and diluted (common shareholders) $(0.04) $(11.52)
    Net income per share, discontinued operations – basic and diluted (common shareholders) $-  $11.29 
             
    Weighted average common shares outstanding  5,458,564   365,231 



    BIO GREEN MED SOLUTION, INC.


    CONSOLIDATED BALANCE SHEET

    (In $000s, except share, per share, and liquidation preference amounts)

      March 31,  December 31, 
      2026  2025 
           
    ASSETS        
    Current assets:        
    Cash and cash equivalents $3,339  $3,505 
    Inventory  947   1,384 
    Accounts receivable  1,188   1,257 
    Prepaid expenses and other current assets  148   110 
    Total current assets  5,622   6,256 
             
    Property and equipment, net Property and equipment, net  138   137 
    Right-of-use lease asset  10   12 
    Goodwill  1,570   1,570 
    Property and equipment, net Non-current deposits  224   210 
    Total assets $7,564  $8,185 
    LIABILITIES AND STOCKHOLDERS' EQUITY        
    Current liabilities:        
    Accounts payable $256  $617 
    Accrued and other current liabilities  540   715 
    Total current liabilities  796   1,332 
    Lease liability  -   2 
    Other liabilities  8   9 
    Total liabilities  804   1,343 
             
    Stockholders' equity  6,760   6,842 
    Total liabilities and stockholders' equity $7,564  $8,185 





    Primary Logo

    Get the next $BGMS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BGMS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BGMS
    SEC Filings

    View All

    SEC Form 10-Q filed by Bio Green Med Solution Inc.

    10-Q - Bio Green Med Solution, Inc. (0001130166) (Filer)

    5/15/26 4:16:23 PM ET
    $BGMS

    Bio Green Med Solution Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Bio Green Med Solution, Inc. (0001130166) (Filer)

    5/14/26 4:25:36 PM ET
    $BGMS

    SEC Form DEFR14A filed by Bio Green Med Solution Inc.

    DEFR14A - Bio Green Med Solution, Inc. (0001130166) (Filer)

    5/1/26 4:27:00 PM ET
    $BGMS

    $BGMS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

    KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ:BGMS, "BGMS" or the "Company")), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced first quarter financial results and provided a business update. Highlights of the first quarter ended March 31, 2026, or in some cases shortly thereafter, include:  ●In March, trading of the Company's 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol "BGMSP") was suspended and a Form 25-NSE was filed with the Securities and Exchange Commission, which removed the Company's securities from lis

    5/14/26 4:15:00 PM ET
    $BGMS

    Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

    SUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company"), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale of E-Commerce Brand Portfolio (the "Asset Sale") The Company has signed a definitive agreement with Trademark Global, LLC ("Trademark") for the sale of assets associated with its marquee brands: Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct. Under the terms of the purchase agreement for the Asset Sale, Trademark will acquire the worldwide business of sourcing, marketing, and selling products under th

    4/28/26 8:00:00 AM ET
    $ATER
    $BGMS
    $BTTC
    Home Furnishings
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

    KUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the "Company" or "we," formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ:BGMS), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced fourth quarter and full year 2025 financial results and provided a business update. "2025 was a productive year for BGMS, marked by the acquisition of Fitters Sdn. Bhd., a fire safety materials and equipment company, on September 12, 2025, the liquidation of our U.K. subsidiary and the sale of our Plogosertib drug, transactions which strengthened our balance sheet. We used this momentum to

    3/30/26 4:15:00 PM ET
    $BGMS

    $BGMS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Doris Wong Sing Ee was granted 300,178 shares, increasing direct ownership by 37% to 1,111,131 units (SEC Form 4)

    4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

    11/13/25 6:00:01 PM ET
    $BGMS

    Chief Financial Officer Kiu Cu Seng was granted 200,000 shares (SEC Form 4)

    4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

    11/13/25 6:00:02 PM ET
    $BGMS

    Large owner Ong Yee Lung acquired 467,535 shares (SEC Form 4)

    4 - Bio Green Med Solution, Inc. (0001130166) (Issuer)

    11/5/25 6:00:03 PM ET
    $BGMS

    $BGMS
    Leadership Updates

    Live Leadership Updates

    View All

    Aterian, Inc. Announces Definitive Agreement for the Sale of its Marquee Brand Portfolio for $18 Million Subject to Adjustments

    SUMMIT, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- Aterian, Inc. (NASDAQ:ATER) ("Aterian" or the "Company"), a consumer products company, today announced separate transactions related to its previously announced Strategic Alternative Process. Sale of E-Commerce Brand Portfolio (the "Asset Sale") The Company has signed a definitive agreement with Trademark Global, LLC ("Trademark") for the sale of assets associated with its marquee brands: Mueller Living, PurSteam, hOmeLabs, Squatty Potty, Healing Solutions, and Photo Paper Direct. Under the terms of the purchase agreement for the Asset Sale, Trademark will acquire the worldwide business of sourcing, marketing, and selling products under th

    4/28/26 8:00:00 AM ET
    $ATER
    $BGMS
    $BTTC
    Home Furnishings
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $BGMS
    Financials

    Live finance-specific insights

    View All

    BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

    KUALA LUMPUR, MALAYSIA, May 14, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ:BGMS, "BGMS" or the "Company")), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced first quarter financial results and provided a business update. Highlights of the first quarter ended March 31, 2026, or in some cases shortly thereafter, include:  ●In March, trading of the Company's 6% Convertible Exchangeable Preferred Stock (listed on The Nasdaq Capital Market under the symbol "BGMSP") was suspended and a Form 25-NSE was filed with the Securities and Exchange Commission, which removed the Company's securities from lis

    5/14/26 4:15:00 PM ET
    $BGMS

    BIO GREEN MED SOLUTION REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

    KUALA LUMPUR, MALAYSIA, March 30, 2026 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. ("BGMS," the "Company" or "we," formerly Cyclacel Pharmaceuticals, Inc.) (NASDAQ:BGMS), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced fourth quarter and full year 2025 financial results and provided a business update. "2025 was a productive year for BGMS, marked by the acquisition of Fitters Sdn. Bhd., a fire safety materials and equipment company, on September 12, 2025, the liquidation of our U.K. subsidiary and the sale of our Plogosertib drug, transactions which strengthened our balance sheet. We used this momentum to

    3/30/26 4:15:00 PM ET
    $BGMS

    Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update

    KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today announced third quarter financial results and provided a business update. Highlights of the third quarter ended September 30, 2025, or in some cases shortly thereafter, include: In July, the Company implemented a one-for-fifteen reverse stock split effective on July 7, 2025 on which day the Company's common stock began trading on a split-adjusted basis in an effort to meet the share bid

    11/13/25 4:40:00 PM ET
    $BGMS